Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke

@article{Kapil2017AntiplateletAA,
  title={Antiplatelet and Anticoagulant Therapies for Prevention of Ischemic Stroke},
  author={Nikhil Kapil and Y. Datta and Naila Alakbarova and E. Bershad and M. Selim and D. Liebeskind and Ornina Bachour and G. H. Rao and A. Divani},
  journal={Clinical and Applied Thrombosis/Hemostasis},
  year={2017},
  volume={23},
  pages={301 - 318}
}
  • Nikhil Kapil, Y. Datta, +6 authors A. Divani
  • Published 2017
  • Medicine
  • Clinical and Applied Thrombosis/Hemostasis
  • Ischemic stroke represents one of the leading causes of death and disability in both the United States and abroad, particularly for patients with prior ischemic stroke or transient ischemic attack (TIA). A quintessential aspect of secondary stroke prevention is the use of different pharmacological agents, mainly antiplatelets and anticoagulants. Antiplatelets and anticoagulants exhibit their effect by blocking the activation pathways of platelets and the coagulation cascade, respectively… CONTINUE READING
    18 Citations
    Impact of Edoxaban on Thrombin-Dependent Platelet Aggregation
    • J. Sokol, F. Nehaj, +6 authors J. Staško
    • Medicine
    • Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis
    • 2020
    Flow Cytometric Assessment of Endothelial and Platelet Microparticles in Patients With Atrial Fibrillation Treated With Dabigatran
    Antithrombotic Preventive Medication Prescription Redemption and Socioeconomic Status in Hungary in 2016: A Cross-Sectional Study
    • PDF
    Influenza vaccination and risk for cardiovascular events: a nationwide self-controlled case series study
    • PDF
    The use of nanotechnology in cardiovascular disease
    • 14
    • PDF

    References

    SHOWING 1-10 OF 113 REFERENCES
    A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke.
    • 1,075
    Review and management of side effects associated with antiplatelet therapy for prevention of recurrent cerebrovascular events
    • 32
    The PRoFESS trial: future impact on secondary stroke prevention
    • H. Diener
    • Medicine
    • Expert review of neurotherapeutics
    • 2007
    • 12
    The Effectiveness of Dual Antiplatelet Treatment in Acute Ischemic Stroke Patients with Intracranial Arterial Stenosis: A Subgroup Analysis of CLAIR Study
    • X. Wang, W. Lin, +7 authors K. L. Wong
    • Medicine
    • International journal of stroke : official journal of the International Stroke Society
    • 2013
    • 39
    Dabigatran Etexilate: A New Oral Thrombin Inhibitor
    • 320
    • Highly Influential
    Direct thrombin inhibitors.
    • 93
    Comparison of warfarin and aspirin for symptomatic intracranial arterial stenosis
    • 337